共 559 条
[1]
Pai SI(2012)HPV-associated head and neck cancers Otolaryngol. Clin. N. Am. 45 xi-xii
[2]
Siegel RL(2019)Cancer statistics CA Cancer J. Clin. 69 7-34
[3]
Miller KD(2017)Evidence-based treatment options in recurrent and/or metastatic squamous cell carcinoma of the head and neck Front. Oncol. 7 72-7356
[4]
Jemal A(2002)Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res. 62 7350-46
[5]
Argiris A(2012)Current treatment options for metastatic head and neck cancer Curr. Treat. Options in Oncol. 13 35-1630
[6]
Harrington KJ(2017)Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies Head Neck 39 1621-1115
[7]
Tahara M(2017)Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial Lancet Oncol. 18 1104-1867
[8]
Schulten J(2016)Nivolumab for recurrent squamous-cell carcinoma of the head and neck N. Engl. J. Med. 375 1856-72
[9]
Chomette P(2010)Cancer of the oral cavity and oropharynx Cancer Imaging 10 62-350
[10]
Ferreira Castro A(2009)Lifestyle risk factors for oral cancer Oral Oncol. 45 340-300